000 01641 a2200397 4500
005 20250516113203.0
264 0 _c20130426
008 201304s 0 0 eng d
022 _a1557-3265
024 7 _a10.1158/1078-0432.CCR-12-0178
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJanku, Filip
245 0 0 _aOutcomes of phase II clinical trials with single-agent therapies in advanced/metastatic non-small cell lung cancer published between 2000 and 2009.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cNov 2012
300 _a6356-63 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aClinical Trials, Phase II as Topic
650 0 4 _aDisease-Free Survival
650 0 4 _aGefitinib
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aMulticenter Studies as Topic
650 0 4 _aMultivariate Analysis
650 0 4 _aQuinazolines
_xtherapeutic use
650 0 4 _aTreatment Outcome
700 1 _aBerry, Donald A
700 1 _aGong, Jing
700 1 _aParsons, Henrique A
700 1 _aStewart, David J
700 1 _aKurzrock, Razelle
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 18
_gno. 22
_gp. 6356-63
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-12-0178
_zAvailable from publisher's website
999 _c22137776
_d22137776